Delcath taps Miao as CFO

Delcath Systems  ($DCTH) has named Graham Miao as CFO. David McDonald, who has served as the company's CFO since 2009, will assume the newly created role of executive VP, business development.

Miao joins Delcath from Dun & Bradstreet Corporation, where he served as chief of staff of the Global CFO Organization. Previously, he held the position of executive VP & CFO of Pagoda Pharmaceuticals, a Shanghai-based specialty pharmaceuticals and medical device company focused in urology and allergies. In addition, Miao held positions at Schering-Plough, Pharmacia and J.P. Morgan.

"The timing of Graham Miao's appointment as CFO is part of the planned expansion of our executive leadership team in advance of the expected commercial launch of our Hepatic CHEMOSAT Delivery System at the end of this year," CEO Eamonn Hobbs explained in a statement. "His knowledge of the global pharmaceutical industry landscape and experience in both established and development stage pharmaceutical/medical device companies will bring additional strategic insights as well."

- check out the Delcath announcement

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.